DOCS is a division of ICON plc
Collection of your Personal Information
This applies to all information collected or submitted on the iconplc.com website. We will ask you when we need information that personally identifies you ("personal information", "personal information data" or "data" as used herein) or allows us to contact you. Personal information collected by iconplc.com is often limited to e-mail address, language, country or location, but may include other information when needed to provide a requested service, where an employment opportunity is being processed or where services as an Investigator in a clinical trial are being offered. We collect information in several ways, outlined below:
1. On some pages you can register to receive information on an automated basis. The type of information you can register to receive in this manner included general corporate information about DOCS such as:
News and presentations
Investor Relations information
Annual & Interim Reports and other public financial information
Other General Information updates
The personal information collected when you register to receive information on an automated basis is your e-mail address. You will have the option of cancelling your registration and removing your e-mail from the database on each occasion that you receive an automated e-mail alert, by clicking on an unsubscribe link on each e-mail alert message.
2. On some pages you may choose to provide personal information about yourself if you are interested in pursuing an employment opportunity with DOCS, or if you are interested in providing clinical trial Investigator services to DOCS. In each case the information requested will be dependent upon the area of interest being pursued.
3. On some pages you may choose to register to receive access to web casts, periodic updates or information on specific DOCS services. Generally the personal information collected in such cases is your name, title, company and e-mail address. This information is collected for qualification and aggregate measurement purposes only.
4. On some pages you can register to receive customized information. This information is generally collected on "Contact Us" forms where you may choose to be contacted by DOCS. The personal information collected in these cases include your name, title, company, address, contact details and e-mail address.
5. www.docsglobal.com also collects certain information about your computer hardware and software. This information may include; your IP address, browser type, operating system, domain name, access times and referring Web site addresses. This information is used for the operation of the service, to maintain and monitor quality of the service and to provide general statistics regarding use of docsglobal.com.
Use of your Personal Information
We may use your personal information for the following purposes:
To ensure www.iconplc.com is relevant to your needs.
To deliver services and information about ICON that you request.
To assist ICON in creating and publishing content most relevant to you.
To alert you to updated information about ICON and ICON services if you so request.
To allow you access to limited-entry areas of iconplc.com as appropriate.
ICON respects the privacy rights and interests of its web site visitors and the following principles will be applied by ICON when dealing with personal information data:
Data Privacy Principles
Data will be collected for the purposes specified above and used accordingly. The collection and processing of the data will be limited to these purposes and you are hereby informed in advance of the purposes and uses of such data.
Data will be adequate, relevant and not excessive relative to the purposes for which they are processed.
Data will be as accurate as possible and, where necessary, kept up to date.
Data will not be kept longer than is appropriate or necessary for the purposes for which it is being processed or local legal requirements.
Data will be collected, used and retained in accordance with the legal rights of the data subjects.
Appropriate technical and physical measures will be taken to prevent unauthorised access, accidental loss, destruction or damage to data and any unauthorised organisation, disclosure or processing.
We store the information you provide in a secure electronic database in order to provide you with the information and/or services you request. The information is stored for the lifetime of the database unless you request that it be removed.
Processing of Personal Information
This site and the electronic database have security measures in place to protect the loss, misuse unauthorized access or disclosure, alteration or destruction of the information under our control.
By submitting your personal information you agree that ICON may process it for the purposes and in accordance with the principles outlined herein.
ICON processes personal information data fairly and lawfully for the purposes as outlined herein only.
Processing for these purposes includes obtaining, recording, holding, organising, transferring, adapting, amending, recovering, consulting, using, limiting, disclosure by transmission, dissemination or otherwise making available, aligning, blocking, destroying and erasing data. In the case of processing employment opportunities with ICON processing of data may include, but is not limited, to:
work history/job data
This list is not exhaustive and may be changed and/or added to from time to time.
Subject to local legal requirements, ICON may use external services to collect, process and/or validate personal information data. ICON requires that any such external service will ensure adequate protection for personal information data and complies with local legal requirements.
ICON may collect candidate feedback and opinions periodically (e.g. surveys) for business purposes, such as improving processes, subject to local legal requirements. You may respond to these surveys voluntarily or may elect not to respond and will not suffer reprisals for your decision. These guidelines will be applicable to personal information provided as response to the surveys.
To operate as a global business it may be necessary to process and transfer personal information data within ICON businesses. This may involve transferring personal information data outside the European Economic Area (EEA) to the USA and elsewhere.
Processing and/or transfer of personal information data and release of such information within ICON and/or to third parties outside the European Economic Area is subject to local law and, where required, will be subject to your consent, as well as ensuring adequate security measures.
Disclosure to Third Parties
ICON may be obliged to disclose certain personal information data to third parties such as Government Authorities.
It may be necessary to disclose certain personal information data to a supplier or contractor organisation supplying services which require the use and/or creation of personal information data.
It may also be necessary to disclose personal information data so as to protect the legal interests and other rights of ICON, subject to local legal requirements.
ICON has in place security to protect manual and electronic processing of personal information data and prevent its misuse, subject to local legal requirements.
ICON also ensures adequate security is observed by third parties and affiliates processing personal information data on behalf of ICON, subject to local legal requirements.
Sensitive Personal Data
ICON ensures special protection for Sensitive Personal Data. This is defined by ICON as:
Except as described herein, we will not otherwise use or disclose any of your personal information, except to the extent reasonably necessary:
Your Access To Personal information Data
You have the right to see personal information that ICON holds about you (subject to certain legal limitations).
To do this you should refer to "Contact Information" below.
ICON will confirm your rights of access to such personal information data. This may include the origin of such data, the purposes for which it has been collected, processed and transferred and the recipients of such data.
ICON will allow you to view your personal information data within a reasonable period, within relevant legal time limits and subject to local legal requirements.
You are encouraged to ensure that personal information data is kept up to date and amend any such data, which is inaccurate or out of date (e.g. name and address).
If you disagree with the accuracy or completeness of any personal information data, please notify ICON in accordance with "Contact Information"; below ICON will endeavour to resolve any issues concerning your personal information data in accordance with relevant procedures.
Protection of Children's Personal Information
iconplc.com is a general audience site and no part of the site is structured to attract children. It is ICON's view that the nature of the subject matter is unlikely to be of general interest to children but notwithstanding this, ICON does not knowingly collect any personal information from children.
US/EU and US/Swiss Safe Harbor Compliance
ICON’s Safe Harbor Certification can be found here
ICON adheres to the US/EU and the US/Swiss Safe Harbor Privacy Principles in connection with the transfer of personal data from the European Economic Area and Switzerland to the US. If you feel that ICON has not abided by the US/EU and the US/Swiss Safe Harbor Privacy Principles, you may contact ICON or the US Federal Trade Commission.
For more information, including ICON’s Safe Harbor policy, please click here to view this information.
Notification of Changes
Questions or comments related to this policy should be submitted to the ICON Global Data Protection Officer as follows:
Global Data Protection Officer, ICON plc, South County Business Park, Leopardstown, Dublin 18, Ireland
The new feature rich website provides enhanced functionality with user friendly navigation.
DOCS’ parent company, ICON plc, today announced that it has agreed, subject to closing conditions, to acquire the Clinical Trial Services Division of Cross Country Healthcare, Inc. (NASDAQ:CCRN), a leader in healthcare staffing services. The transaction is expected to close during the first quarter of 2013.
La société: Notre client est un leader mondial au savoir-faire reconnu dans les dispositifs médicaux cardiovasculaires figurant parmi le TOP 5 des fabricants de pacemakers, défibrillateurs implantables et de valves cardiaques. Date de début du contrat : asap Poste : Ingénieur Traitement de signal / Biomédical – BAC+5 minimum Durée : Prestation de 3 mois renouvelable 1 fois Poste basé à Clamart – déplacement ponctuel à prévoir à Rennes
Do you have monitor experience and are you looking for a broad Clinical Research Associate role on a National level? Apply!
Heb je ervaring als Regulatory Affairs Officer en wil je ervaring opdoen binnen de R & D afdeling van een marktleider in generieke medicijnen die zich in sterke mate bezig houdt met de ontwikkeling, productie en verkoop van innovatieve geneesmiddelen? Solliciteer!
Do you have more then ten years of Global Project Management experience on multinational trails and are you looking for a new challenge at a fast-growing academic research organization? Apply!
Our client is a global, research-focused healthcare company with Group Headquarters in Basel, Switzerland. They have played a pioneering role in UK healthcare since 1908. Today, they are the leading in-vitro diagnostics company in the UK and the leading provider of pharmaceutical treatments for cancer and viral diseases. They are also a major supplier of medicines for the treatment of transplantation, virology, bone and rheumatology and renal anaemia. In total, their UK pharmaceutical and diagnostics businesses employ nearly 2,000 people. As part of their expansion, there are looking to recruit for a Clinical Trials Assistant to be responsible for the co-ordination and support of high quality Clinical Trials and projects, ensuring standardisation and consistency of delivery across studies in accordance with current best practices: meeting the requirements of the specific brand strategy and thereby supporting the UK Pharma business.